Restor3d expands into robotics and navigation

restore3dThe leading medical device company in the field of custom, 3D-printed orthopedic implants, announced its strategic expansion into robotics and navigation with the appointment of experienced executives Larry Hazboun and Kirsten Wedding.

The company, which specializes in the production of implants perfectly tailored to the anatomical characteristics of individual patients, uses advanced 3D printing technologies to develop implants with optimal osseointegration. This adaptation allows for individualized treatment approaches aimed at improving patients’ healing and recovery. With the new step towards robotics and navigation, Restor3d plans to improve the surgical use of these implants through high-precision technologies.

“We welcome Larry Hazboun, SVP of Robotics, and Kirsten Weiding, SVP of Hip & Knee,” said Ken Gall, CCO and co-founder of Restor3d. “The addition of robotics and navigation technologies is a natural complement to customization and a perfect complement to our patient-specific implants. By integrating these technologies with our patient-specific implants and 3D-printed tools, Restor3d is able to offer a more comprehensive approach to personalized patient care.”

Larry Hazboun, formerly of Globus Medical, brings extensive experience in developing navigation and robotics systems for spine surgery. His expertise, which he also brings to Mako Surgical Corp. in developing robotic platforms, will be critical to achieving Restor3d’s new goals. Christine Wedding, with her background in strategic business development and product management, rounds out the leadership team with her extensive experience in marketing and implementing orthopedic technologies.

With this strategic expansion, Restor3d strengthens its position as an innovative player in personalized medicine. The combination of 3D printed implants and advanced surgical technologies underscores the company’s commitment to sustainably shape the future of orthopedics and improve treatment outcomes for patients worldwide.